Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy for Post-Operative Inflammation in Colorectal Cancer
NCT02746432Phase 4Unknown
- Sponsor
- King Saud University
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of regular human insulin in colorectal cancer (CRC), sponsored by King Saud University. Status: unknown.
02
Drugs
regular human insulin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02746432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746432.